V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210003284 | 210010491 | 1.58 | 85 | Palliative (P) | 2016-05-04 | 2016-05-25 | Eribulin | Y | N | ERIBULIN | 101831786 |
| 210003287 | 210010492 | 1.7 | 89 | null | 2018-05-16 | 2018-08-31 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100051775 |
| 210003290 | 210010494 | 1.66 | 64.4 | Neo-adjuvant (N) | 2019-01-23 | 2019-04-19 | Carboplatin AUC 6 - 10 | 01 | N | CARBOPLATIN | 100107566 |
| 210003293 | 210010495 | 1.65 | 70 | null | 2019-07-13 | 2019-07-15 | GemCarbo Days 1+8 | 02 | null | CARBOPLATIN + GEMCITABINE | 101260674 |
| 210003295 | 210010496 | 1.6 | 71.6 | Palliative (P) | 2020-04-04 | 2020-04-04 | Palbociclib | 02 | N | TRIAL UNSPECIFIED | 101706298 |
| 210003296 | 210010497 | 1.56 | 82.3 | Palliative (P) | 2020-04-02 | 2020-05-02 | Epirubicin | null | N | ABEMACICLIB | 100768044 |
| 210003297 | 210010498 | null | null | Palliative (P) | 2020-08-19 | 2020-08-26 | NAB PACLITAXEL | 02 | N | FEC | 101440982 |
| 210003298 | 210010499 | 1.64 | 106.9 | null | 2020-02-02 | 2020-04-13 | Carboplatin + Docetaxel | null | null | LIPOSOMAL DOXORUBICIN | 100231330 |
| 210003299 | 210010500 | 1.7 | 69.6 | Neo-adjuvant (N) | null | 2018-08-02 | Capecitabine | 02 | N | CAPECITABINE | 101705452 |
| 210003300 | 210010501 | 1.63 | 97.1 | Palliative (P) | 2017-08-20 | 2017-09-02 | PERTUZUMAB + TRASTUZUMAB | 02 | N | PERTUZUMAB + TRASTUZUMAB | 100201936 |
| 210003301 | 210010502 | 1.7 | 65 | Palliative (P) | 2020-04-09 | 2020-04-23 | GEMCARBO | 02 | N | CARBOPLATIN + GEMCITABINE | 100804354 |
| 210003302 | 210010503 | 1.63 | 113 | null | 2019-07-16 | 2019-10-02 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100588109 |
| 210003303 | 210010504 | 1.62 | 62.8 | Neo-adjuvant (N) | null | 2020-03-25 | Capecitabine | 02 | N | CAPECITABINE | 100312497 |
| 210003305 | 210010506 | 1.59 | 86.3 | null | 2020-12-16 | 2021-02-08 | OCTREOTIDE | 02 | null | ATEZOLIZUMAB + NAB-PACLITAXEL | 100432458 |
| 210003307 | 210010507 | 1.76 | 93.6 | null | 2019-11-23 | 2020-01-09 | null | null | null | TRIAL UNSPECIFIED | 100133164 |
| 210003309 | 210010508 | 1.72 | 70.1 | null | null | 2019-02-27 | null | 02 | null | LETROZOLE + PALBOCICLIB | 100412354 |
| 210003310 | 210010509 | 1.47 | 65.2 | null | 2017-07-17 | 2017-08-08 | Neratinib | 02 | null | NERATINIB | 100691100 |
| 210003312 | 210010511 | 1.63 | 131 | Adjuvant (A) | 2018-05-07 | 2018-08-07 | Vinorelbine (oral) | 02 | N | VINORELBINE | 100032054 |
| 210003315 | 210010514 | 1.64 | 72.3 | Palliative (P) | null | 2019-10-23 | null | null | N | CYCLOPHOSPHAMIDE + METHOTREXATE | 101120071 |
| 210003319 | 210010515 | 1.62 | 63.75 | null | 2018-02-25 | 2020-07-16 | Capecitabine | 02 | null | CAPECITABINE | 100875292 |
| 210003325 | 210010516 | 1.58 | 71.5 | Adjuvant (A) | 2020-09-02 | 2020-09-18 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | null | N | PACLITAXEL + TRASTUZUMAB | 100793026 |
| 210003326 | 210010517 | 1.58 | 96.1 | null | null | 2019-09-11 | SACITUZUMAB GOVITECAN | null | null | EVEROLIMUS | 101671812 |
| 210003327 | 210010518 | 1.54 | 63 | Adjuvant (A) | 2019-04-05 | 2019-07-01 | null | 02 | N | LETROZOLE + PALBOCICLIB | 100199383 |
| 210003328 | 210010519 | 0 | 63.9 | Neo-adjuvant (N) | 2019-01-29 | 2019-05-07 | null | null | N | TRASTUZUMAB EMTANSINE | 101346546 |
| 210003330 | 210010520 | 1.66 | 87 | null | 2019-02-16 | 2019-06-25 | VINORELBINE | 02 | null | VINORELBINE | 101288731 |
| 210003331 | 210010521 | 1.54 | 128 | Neo-adjuvant (N) | null | 2020-10-13 | FEC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101718877 |
| 210003332 | 210010522 | 1.51 | 56.7 | null | 2019-06-10 | 2019-06-23 | PERTUZUMAB + TRASTUZUMAB | 02 | null | PERTUZUMAB + TRASTUZUMAB | 101530185 |
| 210003333 | 210010523 | 1.55 | 69.6 | Curative (C) | 2019-11-04 | 2019-11-12 | SACITUZUMAB GOVITECAN | 02 | N | ABEMACICLIB + FULVESTRANT | 100273998 |
| 210003334 | 210010524 | 1.78 | 128 | null | 2018-11-18 | 2018-12-01 | Trial Unspecified | null | null | TRIAL UNSPECIFIED | 100478602 |
| 210003336 | 210010525 | 1.58 | 63.4 | Neo-adjuvant (N) | null | 2017-06-24 | GemCarbo Days 1+8 | 02 | N | CARBOPLATIN + GEMCITABINE | 100446841 |
| 210003338 | 210010526 | null | 0 | Unknown (U) | 2016-05-18 | 2016-09-06 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101047007 |
| 210003340 | 210010528 | 1.68 | 70.4 | Palliative (P) | 2019-07-16 | 2022-03-14 | Vinorelbine (oral) | 02 | N | VINORELBINE | 101216382 |
| 210003341 | 210010529 | 1.6 | 81.9 | Palliative (P) | 2019-01-01 | 2019-02-05 | ATEZOLIZUMAB + NAB PACLITAXEL | 02 | N | NAB-PACLITAXEL | 101829987 |
| 210003342 | 210010530 | 1.67 | 65.5 | null | null | 2018-11-15 | Letrozole + Palbociclib | 02 | null | TRIAL UNSPECIFIED | 100510666 |
| 210003344 | 210010531 | null | 101 | Neo-adjuvant (N) | 2018-02-22 | 2018-02-22 | Capecitabine | null | Y | CAPECITABINE | 100143902 |
| 210003348 | 210010533 | null | 87.3 | Neo-adjuvant (N) | 2020-12-08 | 2020-12-30 | CARBOPLATIN | N | N | CARBOPLATIN | 100405639 |
| 210003351 | 210010534 | 1.6 | 80.4 | Palliative (P) | 2022-01-06 | 2022-01-08 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 101572905 |
| 210003352 | 210010535 | 0 | 124.4 | Adjuvant (A) | 2016-12-30 | 2016-12-31 | null | null | N | CARBOPLATIN + DOCETAXEL | 100260471 |
| 210003353 | 210010536 | null | 65.1 | Neo-adjuvant (N) | null | 2019-02-16 | ROSCO Trial | 02 | N | EPIRUBICIN | 100093309 |
| 210003354 | 210010537 | 1.57 | 94.1 | Palliative (P) | 2018-11-21 | 2018-12-08 | null | 02 | N | EVEROLIMUS | 101398167 |
| 210003355 | 210010538 | 0 | 112.4 | null | null | 2020-04-07 | CARBOPLATIN | 02 | null | CARBOPLATIN | 100255752 |
| 210003358 | 210010541 | null | 75.2 | null | null | 2016-11-02 | GemCarbo Days 1+8 | N | null | CARBOPLATIN + GEMCITABINE | 100534008 |
| 210003361 | 210010543 | 1.72 | 84.1 | Adjuvant (A) | 2016-07-27 | 2017-01-22 | Trial Unspecified | null | N | FULVESTRANT + PALBOCICLIB | 100315102 |
| 210003364 | 210010544 | 1.61 | 70.2 | Adjuvant (A) | 2016-11-18 | 2016-12-02 | CARBOPLATIN + GEMCITABINE | null | N | CARBOPLATIN + GEMCITABINE | 100922596 |
| 210003365 | 210010545 | 1.64 | 66 | null | 2021-03-26 | 2021-04-08 | Capecitabine | null | null | CAPECITABINE | 101816143 |
| 210003370 | 210010547 | null | 82.9 | Palliative (P) | null | 2020-04-08 | null | 02 | N | TRIAL UNSPECIFIED | 100300042 |
| 210003371 | 210010548 | 1.63 | 104 | Adjuvant (A) | 2018-02-16 | 2018-04-11 | Palbociclib | 02 | N | CYTARABINE + RITUXIMAB | 101027926 |
| 210003372 | 210010549 | null | 87.6 | Adjuvant (A) | null | 2019-04-01 | PERTUZUMAB + TRASTUZUMAB | 02 | N | PERTUZUMAB + TRASTUZUMAB | 100784396 |
| 210003374 | 210010550 | 1.61 | 52 | Neo-adjuvant (N) | 2019-03-10 | 2019-03-10 | FEC 60 or 75 | 02 | N | ATEZOLIZUMAB + NAB-PACLITAXEL | 100104750 |
| 210003375 | 210010551 | 1.61 | 68 | null | 2019-07-07 | 2019-09-24 | Capecitabine | 02 | null | CAPECITABINE | 101478107 |